The synthesis and biological properties of new 3-phenoxymethylcephalosporins (1) are described. These compoundsexhibited good antibacterial activity against Gram-positive and Gram-negative bacteria.
Japan. However,there has been no report on 3-phenoxymethylcephalosporins although a few reports on 3-heterocyclic oxymethylcephalosporins have already been published3'4*. 3-Phenoxymethylcephalosporins are of interest from both 1) antibacterial and 2) synthetic points of views; 1) it is well known that electron-withdrawing substituents at C-3 position of the cephalosporin increase antibacterial activity. A 3-phenoxymethylcephalosporin is expected to have enhanced activity to 3-methoxymethylcephalosporin because of the electron-withdrawing nature of phenyl group, 2) reaction of 7/?-aminocephalosporanic acid (7-ACA) with phenol under acidic conditions has been reported to yield exclusively 7/?-amino-3-(o-and /?-hydroxyphenyl)methylcephalosporanic acid via C-alkylation of phenol5). Namely, 7/?-amino-3-phenoxymethylcephalosporanic acid, which would be generated via O-alkylation process, could not be isolated. This indicates synthetic difficulty with 3-phenoxymethylcephalosporin.
In this paper, we describe a synthesis and in vitro antibacterial activities of new 3-phenoxymethylcephalosporins.
Chemistry
Weinvestigated a new method for the synthesis of 3-phenoxymethylcephalosporin. First, we tried the ether synthesis first described by Williamson et al.6); however, the reaction of phenoxide anion with 7^-phenoxyacetyl-3-iodomethyl-3-cephem-4-carboxylate did not afford the desired product. Then we examined the Mitsunobu reaction7* and found that the reaction of 3-hydroxymethylcephalosporin derivative with phenol afforded the desired 3-phenoxymethylcephalosporin derivative. So we applied this method to the synthesis of 3-phenoxymethylcephalosporin (1). The general synthetic route is shown in Scheme 1. The Mitsunobu reaction of diphenylmethyl 3-hydroxymethyl-7/^phenoxyacetamido-3-cephem-4-carboxylate (2)2), which was readily available from 7-ACA, with /?-bromophenol in the presence of triphenylphosphine and dimethyl azodicarboxylate in tetrahydrofuran successfully gave the desired 3-phenoxymethyl compound (3a), together with its J2-isomer (4a) in 1 1% and 8% yields, respectively. The J2-isomer (4a) can be converted to the desired z!3-compound (3a) by a usual manner (oxidation with The phenoxyacetyl side chain of 3a was cleaved by an imino-chloride method8) (phosphorus pentachloride, pyridine and propanol), to afford the amine hydrochloride. The coupling reaction of this amine hydrochloride with 2-(2-tritylaminothiazol-4-yl)-(Z)-2-(trityloxyimino)acetic acid9) afforded a good yield of compound (5a), in which amino arid carboxylic groups are protected by trityl (Tr) and diphenylmethyl groups. The protecting groups of 5a were removed by the reaction with formic acid in methanol at 40°C, and subsequently with trifluoroacetic acid and anisole in methylene chloride under ice-cooling to give the final compound (la) as a salt with trifluoroacetic acid. The compounds lb~le and lg~In were prepared by the same procedure using corresponding phenols. In the synthesis of/?-carboxy compound(lh), diphenylmethyl /?-hydroxybenzoate was used as a phenol fragment. In the synthesis of lo and lp, 2-(2-tritylaminothiazol-4-yl)-(Z)-2-(methoxyimino)acetic acid9) and 2-(2-tritylaminothiazol-4-yl)-(Z)-2-(monofluoromethoxyimino)acetic acid10) were used respectively for the coupling reactions. The methylsulfinyl compound (If) was synthesized from 5j by oxidation with one molar equivalent of raeta-chloroperbenzoic acid, followed by treatment with trifluoroacetic acid.
Antimicrobial Activity The in vitro antibacterial activities of these compounds(trifluoroacetic acid salts) are shown in Table  1 . All of these compoundsexhibited potent activity against broad range of microorganisms. These compound have potent activity especially against Gram-positive bacteria. In comparison with the unsubstituted phenoxyl derivative (lb), the introduction of an electron-withdrawing moiety into the phenyl ring enhances the antibacterial activity. /7-Methylsulflnyl derivative (If) showed superior activity against both
Gram-positive and Gram-negative bacteria to /?-methyl sulfide compound(lj). Introduction of a carboxy function into the phenyl ring (lh) enhanced the activity against Gram-negative bacteria, although the activity against Gram-positive bacteria was very poor. A /^-fluorine substituted compound (lc) showed strong activity against Gram-positive and Gram-negative bacteria, although a /?-bromo compound(la) showed inferior activity against Gram-negative bacteria. Table 2 demonstrates the effect of the position of the substituents. The meta-or /wa-substituted 
acid. Abbreviations mean the same strains as in Table 1. phenoxyl derivatives (lc and ll) were more active than the corresponding ortho-substituted derivative (Ik) against Gram-negative bacteria. However, there was little difference against Gram-positive activity among ortho-, meta-and /w<z-substituted derivatives. Substitution of both meta-and^ara-positions or ortho-and /?<zra-positions in the phenyl ring showed no significant improvement in the activity (lm and In). Among these, a m-fluoro compound(II) had the most potent activity.
Introduction ofmethyl or monofluoromethyl group to the hydroxyimino moiety of the C-7 side chain of m-fluorophenoxy compound (ll) enhanced the Gram-negative activity, but slightly diminished activity against Gram-positive bacteria (lo and lp).
In conclusion, we have synthesized cephalosporin derivatives having a new3-phenoxymethyl substituent and found them to have good antibacterial activity especially against Gram-positive bacteria. The compounds (ll, lo, lp) showed the well-balanced activity against both Gram-positive and Gram-negative bacteria comparable to 3-methoxymethylcephalosporin (lq).
Experimental IR spectra were recorded on a Jasco FT-IR 8300 spectrometer. *H NMR spectra were recorded on a Jeol-270GX (270MHz) spectrometer using TMSas an internal standard. MICs were derermined in nutrient agar medium (Eiken) by the 2-fold dilution method with 107 cfu/ml inoculum size after incubation at 37°C for 18 hours. Dimethyl azodicarboxylate (0.90ml) in dry THF(60ml) was added to a stirred solution of 2 (3.00g), /?-bromophenol (1.17g) and triphenylphosphine (1.80g) in dry THF (60ml) during 15 minutes under ice-cooling. After stirring for another 15 minutes at the same temperature, reaction mixture was diluted with brine and extracted with EtOAc. The extracts were washed with brine and dried over anhydrous Na2SO4.The solvent was removed in vacuo and the residue was chromatographed on a Lobar silica gel column (Merck, silica gel, benzene-MeCN (4 : 1) to give 3a (420mg) and 4a (300mg Anhydrous pyridine (0.28ml) was added to a stirred solution of PC15 (630mg) in CHC13 (14ml) and stirred for 15 minutes. 3a (890mg) in CHC13(6ml) was added to the above reaction mixture under ice-cooling. The mixture was stirred for 1 hour at room temperature and then cooled to -30°C. «-PrOH (1.70ml) was added to the resulting solution, the mixture was gradually warmedto room temperature. The reaction mixture was diluted with CH2C12,washed with brine and dried over Na2SO4. The solvent was removed in vacuo and the residue was triturated with isopropyl ether, and the resulting power was collected by filtration to give diphenylmethyl 7/^amino-3-(4-bromophenoxy)methyl-3-cephem-4-carboxylate hydrochloride (760mg). POC13 (0.15ml) was added to a stirred solution of above amine hydrochloride, 2-(2-tritylaminothiazol-4-yl)-(Z)-2-(trityloxyimino)acetic acid (1.050 g) and diethylaniline (0.93 ml) in CH2C12 (15 ml) under ice-cooling. After stirring for 1 hour, the reaction mixture was poured into ice-water and extracted with EtOAc. The extracts were washed with dil HC1, brine, aqNaHCO3, brine, then dried over Na2SO4. The solvents were removedin vacuo and the residue was chromatographed Table 3 . *H NMR(270MHz) data ofla~lp (DMSO-</6, 3 ppm). Formic acid (5.0ml) was added to a stirred solution of 5a (1.16g) in methanol (5.0ml) at room temperature. After stirring for 1 hour at 40°C, the solvent was removed in vacuo. The residue was dissolved in EtOAc and the solution was washed.with aqNaHCO3. The organic phase was washed with brine and then dried over Na2SO4.The solvent was removed in vacuo and the residue was chromatographed on a silica gel column to give 6a (350mg Trifluoroacetic acid (1.5ml) was added to a stirred solution of 6a (340mg) and anisole (0.5ml) in CH2C12(1.0ml) under ice-cooling. After stirring for 1 hour at the same temperature, isopropyl ether was added to the reaction mixture. The resulting powder was collected by filtration to afford la (213 mg) as a powder. IR (KBr) cm"1 1776, 1675, 1192. *H NMR (Table 3 ).
General Procedure for the Preparation of 3-Phenoxymethyl Compounds

7/^[2-(2-Aminothiazol-4-yl)-(Z)-2-hydroxyiminoacetam cephem-4-carboxylic
Acid Trifluoroacetic Acid Salt (If) Meta-chloroperbenzoic acid (196 mg) was added to a solution of lj (662mg) in a mixture ofmethylene chloride (66.2ml) and methanol (5 ml) at 35~40°C and stirred at the same temperature for 30 minutes. The reaction mixture was poured into ice-NaHCO3solution and extracted with EtOAc. The extracts were washed with brine, dried over Na2SO4 and evaporated to give 660mg crude oil. This oil was chromatographed on silica gel column to afford 6f (198 mg). The obtained 6f was treated in the same way as that described for the synthesis of la to give 135mg of If. IR (KBr) cm"1 1782, 1673, 1200. *H NMR (Table 3) .
